GPRO GoPro | $2.23 +0.9% | 3/27/2024 | Reiterated by | Wedbush | Analyst A. Reese | Neutral | $2.00 | Low | View details for Wedbush rating of GoPro (NASDAQ:GPRO) on 3/27/2024 |
NVCR NovoCure | $14.64 +12.0% | 3/27/2024 | Reiterated by | Wedbush | - | Neutral | $21.00 | Low | View details for Wedbush rating of NovoCure (NASDAQ:NVCR) on 3/27/2024 |
STKS ONE Group Hospitality | $5.07 +26.4% | 3/27/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $5.00 | Low | View details for Wedbush rating of ONE Group Hospitality (NASDAQ:STKS) on 3/27/2024 |
NFLX Netflix | $613.53 -2.5% | 3/27/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $615.00 -> $725.00 | Low | View details for Wedbush rating of Netflix (NASDAQ:NFLX) on 3/27/2024 |
APRE Aprea Therapeutics | $6.07 +2.5% | 3/27/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $9.00 -> $11.00 | Low | View details for Wedbush rating of Aprea Therapeutics (NASDAQ:APRE) on 3/27/2024 |
NKE NIKE | $94.15 +1.7% | 3/27/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $115.00 | Low | View details for Wedbush rating of NIKE (NYSE:NKE) on 3/27/2024 |
|
GME GameStop | $13.17 -15.1% | 3/27/2024 | Target Lowered by | Wedbush | - | Underperform -> Underperform | $6.00 -> $5.60 | Low | View details for Wedbush rating of GameStop (NYSE:GME) on 3/27/2024 |
STOK Stoke Therapeutics | $14.17 +37.7% | 3/26/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $13.00 -> $17.00 | Low | View details for Wedbush rating of Stoke Therapeutics (NASDAQ:STOK) on 3/26/2024 |
STRO Sutro Biopharma | $4.93 +17.9% | 3/26/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $12.00 -> $8.00 | Low | View details for Wedbush rating of Sutro Biopharma (NASDAQ:STRO) on 3/26/2024 |
ATXS Astria Therapeutics | $13.60 +0.5% | 3/26/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $17.00 | Low | View details for Wedbush rating of Astria Therapeutics (NASDAQ:ATXS) on 3/26/2024 |
MSFT Microsoft | $421.43 -0.1% | 3/26/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $475.00 -> $500.00 | Low | View details for Wedbush rating of Microsoft (NASDAQ:MSFT) on 3/26/2024 |
WLDN Willdan Group | $29.20 -0.3% | 3/25/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $30.00 -> $35.00 | Low | View details for Wedbush rating of Willdan Group (NASDAQ:WLDN) on 3/25/2024 |
UMH UMH Properties | $15.84 +1.1% | 3/25/2024 | Reiterated by | Wedbush | Analyst R. Anderson | Neutral | $17.00 | Low | View details for Wedbush rating of UMH Properties (NYSE:UMH) on 3/25/2024 |
CMPX Compass Therapeutics | $2.05 +3.5% | 3/22/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $8.00 | Low | View details for Wedbush rating of Compass Therapeutics (NASDAQ:CMPX) on 3/22/2024 |
DNTH Dianthus Therapeutics | $30.60 -2.9% | 3/22/2024 | Target Raised by | Wedbush | Analyst L. Chico | Outperform -> Outperform | $24.00 -> $33.00 | Low | View details for Wedbush rating of Dianthus Therapeutics (NASDAQ:DNTH) on 3/22/2024 |
DRI Darden Restaurants | $166.97 +2.1% | 3/22/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $187.00 -> $181.00 | Low | View details for Wedbush rating of Darden Restaurants (NYSE:DRI) on 3/22/2024 |
MGPI MGP Ingredients | $85.80 +3.4% | 3/22/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $120.00 | Low | View details for Wedbush rating of MGP Ingredients (NASDAQ:MGPI) on 3/22/2024 |
ASO Academy Sports and Outdoors | $67.90 +3.7% | 3/22/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $80.00 | Low | View details for Wedbush rating of Academy Sports and Outdoors (NASDAQ:ASO) on 3/22/2024 |
RH RH | $297.10 +3.8% | 3/22/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $275.00 | Low | View details for Wedbush rating of RH (NYSE:RH) on 3/22/2024 |
GOOGL Alphabet | $150.87 +0.1% | 3/22/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $160.00 -> $175.00 | Low | View details for Wedbush rating of Alphabet (NASDAQ:GOOGL) on 3/22/2024 |
LULU Lululemon Athletica | $389.46 +0.9% | 3/22/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $548.00 -> $492.00 | Low | View details for Wedbush rating of Lululemon Athletica (NASDAQ:LULU) on 3/22/2024 |
CMG Chipotle Mexican Grill | $2,923.46 -1.1% | 3/22/2024 | Target Raised by | Wedbush | Analyst N. Setyan | Neutral -> Neutral | $2,400.00 -> $2,850.00 | Low | View details for Wedbush rating of Chipotle Mexican Grill (NYSE:CMG) on 3/22/2024 |
IRON Disc Medicine | $60.51 +0.3% | 3/21/2024 | Reiterated by | Wedbush | - | Outperform | $79.00 -> $84.00 | Low | View details for Wedbush rating of Disc Medicine (NASDAQ:IRON) on 3/21/2024 |
WSM Williams-Sonoma | $314.18 +1.9% | 3/21/2024 | Reiterated by | Wedbush | Analyst S. Basham | Outperform -> Outperform | $330.00 | Low | View details for Wedbush rating of Williams-Sonoma (NYSE:WSM) on 3/21/2024 |
GEO The GEO Group | $14.21 -2.1% | 3/21/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $15.00 | Low | View details for Wedbush rating of The GEO Group (NYSE:GEO) on 3/21/2024 |
CXW CoreCivic | $15.66 +0.1% | 3/21/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $18.00 | Low | View details for Wedbush rating of CoreCivic (NYSE:CXW) on 3/21/2024 |
MU Micron Technology | $119.25 +0.4% | 3/21/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $103.00 -> $130.00 | Low | View details for Wedbush rating of Micron Technology (NASDAQ:MU) on 3/21/2024 |
AAPL Apple | $173.31 +2.1% | 3/21/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $250.00 | Low | View details for Wedbush rating of Apple (NASDAQ:AAPL) on 3/21/2024 |
ALIT Alight | $9.79 -0.1% | 3/21/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $13.00 -> $14.00 | Low | View details for Wedbush rating of Alight (NYSE:ALIT) on 3/21/2024 |
TYRA Tyra Biosciences | $16.30 +0.9% | 3/21/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $28.00 | Low | View details for Wedbush rating of Tyra Biosciences (NASDAQ:TYRA) on 3/21/2024 |
KBH KB Home | $69.55 +2.0% | 3/21/2024 | Target Raised by | Wedbush | Analyst J. Mccanless | Neutral -> Neutral | $60.00 -> $64.00 | Low | View details for Wedbush rating of KB Home (NYSE:KBH) on 3/21/2024 |
VOR Vor Biopharma | $2.21 +2.3% | 3/21/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $11.00 | Low | View details for Wedbush rating of Vor Biopharma (NYSE:VOR) on 3/21/2024 |
CHWY Chewy | $15.66 +2.6% | 3/21/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $25.00 | Low | View details for Wedbush rating of Chewy (NYSE:CHWY) on 3/21/2024 |
VERA Vera Therapeutics | $43.83 +5.4% | 3/21/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $21.00 -> $34.00 | Low | View details for Wedbush rating of Vera Therapeutics (NASDAQ:VERA) on 3/21/2024 |
ACET Adicet Bio | $2.33 +4.0% | 3/20/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $5.00 | Low | View details for Wedbush rating of Adicet Bio (NASDAQ:ACET) on 3/20/2024 |
DSGN Design Therapeutics | $3.91 +9.5% | 3/20/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $5.00 | Low | View details for Wedbush rating of Design Therapeutics (NASDAQ:DSGN) on 3/20/2024 |
FUSN Fusion Pharmaceuticals | $21.30
| 3/19/2024 | Downgraded by | Wedbush | Analyst D. Nierengarten | Outperform -> Neutral | $24.00 | N/A | View details for Wedbush rating of Fusion Pharmaceuticals (NASDAQ:FUSN) on 3/19/2024 |
PHVS Pharvaris | $23.50 -0.8% | 3/19/2024 | Reiterated by | Wedbush | Analyst L. Chico | Outperform -> Outperform | $35.00 | Low | View details for Wedbush rating of Pharvaris (NASDAQ:PHVS) on 3/19/2024 |
BLUE bluebird bio | $1.37 +14.2% | 3/19/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $1.72 -> $1.68 | Low | View details for Wedbush rating of bluebird bio (NASDAQ:BLUE) on 3/19/2024 |
ALPN Alpine Immune Sciences | $38.65 +3.2% | 3/19/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $47.00 | Low | View details for Wedbush rating of Alpine Immune Sciences (NASDAQ:ALPN) on 3/19/2024 |
the most reliable asset on earth is making a comeback (Ad) Global tensions have been pushing the price of gold to all time highs…
Just recently, gold peaked at a record $2,000 (and is now closer to $2,200).
And there’s something else critical at play right now in the world’s largest asset.
Because of these critical factors, a lot of massive investment institutions are now pumping more money into gold.
And as we speak, some are even calling for a massive rally in the precious metal. And you can see how it works for FREE when you Click Here |
LEGH Legacy Housing | $20.85 +5.3% | 3/19/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $31.00 -> $25.00 | Low | View details for Wedbush rating of Legacy Housing (NASDAQ:LEGH) on 3/19/2024 |
NCMI National CineMedia | $5.06 -4.2% | 3/19/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $4.50 -> $5.50 | Low | View details for Wedbush rating of National CineMedia (NASDAQ:NCMI) on 3/19/2024 |
NVDA NVIDIA | $902.50 -2.5% | 3/19/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $1,000.00 | Low | View details for Wedbush rating of NVIDIA (NASDAQ:NVDA) on 3/19/2024 |
NKE NIKE | $94.15 +1.7% | 3/19/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $131.00 -> $115.00 | Low | View details for Wedbush rating of NIKE (NYSE:NKE) on 3/19/2024 |
LEN Lennar | $168.50 +1.8% | 3/18/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $130.00 -> $144.00 | Low | View details for Wedbush rating of Lennar (NYSE:LEN) on 3/18/2024 |
TNGX Tango Therapeutics | $7.70 +2.5% | 3/18/2024 | Reiterated by | Wedbush | - | Outperform | $18.00 | Low | View details for Wedbush rating of Tango Therapeutics (NASDAQ:TNGX) on 3/18/2024 |
LOGI Logitech International | $88.46 -2.5% | 3/18/2024 | Reiterated by | Wedbush | - | Neutral | $92.00 | Low | View details for Wedbush rating of Logitech International (NASDAQ:LOGI) on 3/18/2024 |
TSLA Tesla | $179.83 +1.2% | 3/13/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $315.00 | Low | View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 3/13/2024 |
MLTX MoonLake Immunotherapeutics | $50.21 +0.3% | 3/13/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $92.00 | Low | View details for Wedbush rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 3/13/2024 |
LBPH Longboard Pharmaceuticals | $20.98 +4.3% | 3/13/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $32.00 | Low | View details for Wedbush rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 3/13/2024 |
PRPL Purple Innovation | $1.56 +4.7% | 3/13/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $1.25 -> $2.25 | Low | View details for Wedbush rating of Purple Innovation (NASDAQ:PRPL) on 3/13/2024 |
BIRD Allbirds | $0.66 +6.5% | 3/13/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $1.00 -> $0.90 | Low | View details for Wedbush rating of Allbirds (NASDAQ:BIRD) on 3/13/2024 |
TPX Tempur Sealy International | $56.19 +0.2% | 3/13/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $60.00 -> $66.00 | Low | View details for Wedbush rating of Tempur Sealy International (NYSE:TPX) on 3/13/2024 |
INFY Infosys | $17.80 +0.3% | 3/13/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $22.00 | Low | View details for Wedbush rating of Infosys (NYSE:INFY) on 3/13/2024 |
DRI Darden Restaurants | $166.97 +2.1% | 3/15/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $177.00 -> $187.00 | Low | View details for Wedbush rating of Darden Restaurants (NYSE:DRI) on 3/15/2024 |
PGY Pagaya Technologies | $10.27 -2.6% | 3/15/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $18.00 -> $11.50 | Low | View details for Wedbush rating of Pagaya Technologies (NASDAQ:PGY) on 3/15/2024 |
GERN Geron | $3.31 +0.3% | 3/15/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $6.00 | Low | View details for Wedbush rating of Geron (NASDAQ:GERN) on 3/15/2024 |
DECK Deckers Outdoor | $937.90 +0.0% | 3/15/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $895.00 -> $1,000.00 | Low | View details for Wedbush rating of Deckers Outdoor (NYSE:DECK) on 3/15/2024 |
RMBL RumbleON | $6.41 +5.3% | 3/15/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $7.50 -> $7.00 | Low | View details for Wedbush rating of RumbleON (NASDAQ:RMBL) on 3/15/2024 |
DKS DICK'S Sporting Goods | $222.64 +1.9% | 3/15/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $160.00 -> $210.00 | Low | View details for Wedbush rating of DICK’S Sporting Goods (NYSE:DKS) on 3/15/2024 |
SKLZ Skillz | $6.42 +5.2% | 3/15/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $15.00 | Low | View details for Wedbush rating of Skillz (NYSE:SKLZ) on 3/15/2024 |
GETY Getty Images | $4.26 +7.0% | 3/15/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $7.70 | Low | View details for Wedbush rating of Getty Images (NYSE:GETY) on 3/15/2024 |
STKS ONE Group Hospitality | $5.07 +26.4% | 3/15/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $6.00 -> $5.00 | Low | View details for Wedbush rating of ONE Group Hospitality (NASDAQ:STKS) on 3/15/2024 |
NHI National Health Investors | $61.82 +1.9% | 3/18/2024 | Target Raised by | Wedbush | Analyst R. Anderson | Outperform -> Outperform | $64.00 -> $66.00 | Low | View details for Wedbush rating of National Health Investors (NYSE:NHI) on 3/18/2024 |
TSVT 2seventy bio | $5.38 +8.5% | 3/18/2024 | Reiterated by | Wedbush | Analyst D. Nierengarten | Neutral -> Neutral | $5.00 | Low | View details for Wedbush rating of 2seventy bio (NASDAQ:TSVT) on 3/18/2024 |
FENC Fennec Pharmaceuticals | $11.09 +1.8% | 3/18/2024 | Reiterated by | Wedbush | - | Outperform | $16.00 | Low | View details for Wedbush rating of Fennec Pharmaceuticals (NASDAQ:FENC) on 3/18/2024 |
HEAR Turtle Beach | $17.24 +0.3% | 3/14/2024 | Reiterated by | Wedbush | - | Outperform | $14.00 -> $19.00 | N/A | View details for Wedbush rating of Turtle Beach (NASDAQ:HEAR) on 3/14/2024 |
S SentinelOne | $22.69 +2.1% | 3/14/2024 | Target Raised by | Wedbush | - | Overweight -> Overweight | $28.00 -> $32.00 | Low | View details for Wedbush rating of SentinelOne (NYSE:S) on 3/14/2024 |
JACK Jack in the Box | $70.47 +2.8% | 3/14/2024 | Upgraded by | Wedbush | Analyst N. Setyan | Neutral -> Outperform | $79.00 -> $88.00 | Low | View details for Wedbush rating of Jack in the Box (NASDAQ:JACK) on 3/14/2024 |
CLSD Clearside Biomedical | $1.67 -1.2% | 3/13/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $5.00 -> $4.00 | Low | View details for Wedbush rating of Clearside Biomedical (NASDAQ:CLSD) on 3/13/2024 |
BDTX Black Diamond Therapeutics | $4.90 -3.7% | 3/13/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $10.00 | Low | View details for Wedbush rating of Black Diamond Therapeutics (NASDAQ:BDTX) on 3/13/2024 |
GEO The GEO Group | $14.21 -2.1% | 3/13/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $15.00 | Low | View details for Wedbush rating of The GEO Group (NYSE:GEO) on 3/13/2024 |
NCMI National CineMedia | $5.06 -4.2% | 3/12/2024 | Reiterated by | Wedbush | - | Neutral | $4.50 | Low | View details for Wedbush rating of National CineMedia (NASDAQ:NCMI) on 3/12/2024 |
INZY Inozyme Pharma | $7.39 +9.0% | 3/12/2024 | Reiterated by | Wedbush | - | Outperform | $15.00 | Low | View details for Wedbush rating of Inozyme Pharma (NASDAQ:INZY) on 3/12/2024 |
IKNA Ikena Oncology | $1.39
| 3/12/2024 | Reiterated by | Wedbush | - | Outperform | $8.00 | Low | View details for Wedbush rating of Ikena Oncology (NASDAQ:IKNA) on 3/12/2024 |
MU Micron Technology | $119.25 +0.4% | 3/12/2024 | Reiterated by | Wedbush | - | Outperform | $95.00 -> $103.00 | Low | View details for Wedbush rating of Micron Technology (NASDAQ:MU) on 3/12/2024 |
ANAB AnaptysBio | $21.38 -1.0% | 3/12/2024 | Upgraded by | Wedbush | Analyst D. Nierengarten | Neutral -> Outperform | $20.00 -> $34.00 | Low | View details for Wedbush rating of AnaptysBio (NASDAQ:ANAB) on 3/12/2024 |
JANX Janux Therapeutics | $37.92 -2.4% | 3/11/2024 | Reiterated by | Wedbush | - | Outperform | $53.00 | Low | View details for Wedbush rating of Janux Therapeutics (NASDAQ:JANX) on 3/11/2024 |
SPRY ARS Pharmaceuticals | $9.96 -0.4% | 3/11/2024 | Reiterated by | Wedbush | - | Outperform | $19.00 | Low | View details for Wedbush rating of ARS Pharmaceuticals (NASDAQ:SPRY) on 3/11/2024 |
PLTR Palantir Technologies | $24.50 -1.6% | 3/8/2024 | Reiterated by | Wedbush | - | Outperform | $30.00 -> $35.00 | Low | View details for Wedbush rating of Palantir Technologies (NYSE:PLTR) on 3/8/2024 |
PEPG PepGen | $14.09 +7.3% | 3/7/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $21.00 -> $20.00 | Low | View details for Wedbush rating of PepGen (NASDAQ:PEPG) on 3/7/2024 |
ELEV Elevation Oncology | $5.01 +0.2% | 3/7/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $5.00 -> $8.00 | Low | View details for Wedbush rating of Elevation Oncology (NASDAQ:ELEV) on 3/7/2024 |
GBIO Generation Bio | $3.70 +16.7% | 3/7/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $5.00 | Low | View details for Wedbush rating of Generation Bio (NASDAQ:GBIO) on 3/7/2024 |
WSM Williams-Sonoma | $314.18 +1.9% | 3/7/2024 | Target Raised by | Wedbush | Analyst S. Basham | Outperform -> Outperform | $230.00 -> $280.00 | Low | View details for Wedbush rating of Williams-Sonoma (NYSE:WSM) on 3/7/2024 |
NYCB New York Community Bancorp | $3.34 +4.4% | 3/7/2024 | Target Lowered by | Wedbush | Analyst D. Chiaverini | Underperform -> Underperform | $3.50 -> $3.00 | N/A | View details for Wedbush rating of New York Community Bancorp (NYSE:NYCB) on 3/7/2024 |
SOFI SoFi Technologies | $7.36 +2.2% | 3/6/2024 | Reiterated by | Wedbush | Analyst D. Chiaverini | Underperform -> Underperform | $3.00 | Low | View details for Wedbush rating of SoFi Technologies (NASDAQ:SOFI) on 3/6/2024 |
OCS Oculis | $11.91 +2.6% | 3/6/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $29.00 | Low | View details for Wedbush rating of Oculis (NASDAQ:OCS) on 3/6/2024 |
GOSS Gossamer Bio | $1.17 -4.9% | 3/6/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $6.00 | Low | View details for Wedbush rating of Gossamer Bio (NASDAQ:GOSS) on 3/6/2024 |
HEAR Turtle Beach | $17.24 +0.3% | 3/6/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $14.00 | N/A | View details for Wedbush rating of Turtle Beach (NASDAQ:HEAR) on 3/6/2024 |
TCRX TScan Therapeutics | $8.30 +3.9% | 3/6/2024 | Reiterated by | Wedbush | - | Outperform | $9.00 -> $10.00 | Low | View details for Wedbush rating of TScan Therapeutics (NASDAQ:TCRX) on 3/6/2024 |
The Small Biotech with a BIG Cancer Solution (Ad) There's a new cancer treatment so precise, it's been called a "smart bomb."
One that can deliver a toxic payload directly to tumors while bypassing healthy cells. Get the full story here >>> |
ITOS iTeos Therapeutics | $13.17 +6.6% | 3/6/2024 | Reiterated by | Wedbush | - | Outperform | $25.00 -> $18.00 | Low | View details for Wedbush rating of iTeos Therapeutics (NASDAQ:ITOS) on 3/6/2024 |
APGE Apogee Therapeutics | $68.11 +3.6% | 3/5/2024 | Reiterated by | Wedbush | - | Outperform | $40.00 -> $87.00 | Low | View details for Wedbush rating of Apogee Therapeutics (NASDAQ:APGE) on 3/5/2024 |
ATXS Astria Therapeutics | $13.60 +0.5% | 3/5/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $17.00 | Low | View details for Wedbush rating of Astria Therapeutics (NASDAQ:ATXS) on 3/5/2024 |
LEN Lennar | $168.50 +1.8% | 3/5/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $130.00 | Low | View details for Wedbush rating of Lennar (NYSE:LEN) on 3/5/2024 |
TDUP ThredUp | $1.94 +0.5% | 3/5/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $4.00 | Low | View details for Wedbush rating of ThredUp (NASDAQ:TDUP) on 3/5/2024 |
SFIX Stitch Fix | $2.44 +0.4% | 3/5/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $4.00 -> $3.00 | Low | View details for Wedbush rating of Stitch Fix (NASDAQ:SFIX) on 3/5/2024 |
CCS Century Communities | $94.61 +1.9% | 3/5/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral -> Neutral | $92.00 | Low | View details for Wedbush rating of Century Communities (NYSE:CCS) on 3/5/2024 |
CRWD CrowdStrike | $322.25 -2.4% | 3/5/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $278.00 -> $350.00 | Low | View details for Wedbush rating of CrowdStrike (NASDAQ:CRWD) on 3/5/2024 |
MELI MercadoLibre | $1,522.65 -1.0% | 3/5/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $2,000.00 | Low | View details for Wedbush rating of MercadoLibre (NASDAQ:MELI) on 3/5/2024 |
SE SEA | $53.59 -3.6% | 3/5/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $45.00 -> $72.00 | Low | View details for Wedbush rating of SEA (NYSE:SE) on 3/5/2024 |
CELH Celsius | $83.43 -8.5% | 3/4/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $75.00 -> $90.00 | Low | View details for Wedbush rating of Celsius (NASDAQ:CELH) on 3/4/2024 |
FUBO fuboTV | $1.56 +3.3% | 3/4/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $5.00 | Low | View details for Wedbush rating of fuboTV (NYSE:FUBO) on 3/4/2024 |
IMAX IMAX | $16.16 +2.9% | 3/4/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $22.00 | Low | View details for Wedbush rating of IMAX (NYSE:IMAX) on 3/4/2024 |
ZS Zscaler | $193.48 -1.1% | 3/1/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $250.00 -> $260.00 | Low | View details for Wedbush rating of Zscaler (NASDAQ:ZS) on 3/1/2024 |
SOUN SoundHound AI | $5.93 +2.1% | 3/1/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $5.00 -> $9.00 | Low | View details for Wedbush rating of SoundHound AI (NASDAQ:SOUN) on 3/1/2024 |
NYCB New York Community Bancorp | $3.34 +4.4% | 3/1/2024 | Target Lowered by | Wedbush | Analyst D. Chiaverini | Underperform -> Underperform | $5.00 -> $3.50 | Low | View details for Wedbush rating of New York Community Bancorp (NYSE:NYCB) on 3/1/2024 |
VRNA Verona Pharma | $16.50 +2.2% | 3/1/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $33.00 | Low | View details for Wedbush rating of Verona Pharma (NASDAQ:VRNA) on 3/1/2024 |
MLTX MoonLake Immunotherapeutics | $50.21 +0.3% | 3/1/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $92.00 | Low | View details for Wedbush rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 3/1/2024 |
XENE Xenon Pharmaceuticals | $43.00 +0.8% | 3/1/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $46.00 -> $51.00 | Low | View details for Wedbush rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 3/1/2024 |
ORIC ORIC Pharmaceuticals | $13.47
| 3/1/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $12.00 -> $20.00 | Low | View details for Wedbush rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 3/1/2024 |
NUVB Nuvation Bio | $3.96 +37.5% | 3/1/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $5.00 | Low | View details for Wedbush rating of Nuvation Bio (NYSE:NUVB) on 3/1/2024 |
GRBK Green Brick Partners | $59.77 +2.0% | 3/1/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $45.00 | Low | View details for Wedbush rating of Green Brick Partners (NASDAQ:GRBK) on 3/1/2024 |
BBY Best Buy | $81.85 +2.2% | 3/1/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $75.00 -> $85.00 | Low | View details for Wedbush rating of Best Buy (NYSE:BBY) on 3/1/2024 |
NTAP NetApp | $105.22 +0.5% | 3/1/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $85.00 -> $100.00 | Low | View details for Wedbush rating of NetApp (NASDAQ:NTAP) on 3/1/2024 |
LSEA Landsea Homes | $14.07 +3.8% | 3/1/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $16.00 | Low | View details for Wedbush rating of Landsea Homes (NASDAQ:LSEA) on 3/1/2024 |
PZZA Papa John's International | $66.26 +1.3% | 3/1/2024 | Reiterated by | Wedbush | Analyst N. Setyan | Outperform -> Outperform | $87.00 | Low | View details for Wedbush rating of Papa John’s International (NASDAQ:PZZA) on 3/1/2024 |
PSTG Pure Storage | $52.56 +0.7% | 2/29/2024 | Reiterated by | Wedbush | - | Outperform | $50.00 | Low | View details for Wedbush rating of Pure Storage (NYSE:PSTG) on 2/29/2024 |
SRPT Sarepta Therapeutics | $130.23 +1.5% | 2/29/2024 | Reiterated by | Wedbush | - | Outperform | $224.00 | Low | View details for Wedbush rating of Sarepta Therapeutics (NASDAQ:SRPT) on 2/29/2024 |
KROS Keros Therapeutics | $64.66 -2.2% | 2/29/2024 | Reiterated by | Wedbush | - | Outperform | $86.00 | Low | View details for Wedbush rating of Keros Therapeutics (NASDAQ:KROS) on 2/29/2024 |
SBRA Sabra Health Care REIT | $14.58 +1.9% | 2/29/2024 | Reiterated by | Wedbush | - | Outperform | $17.00 | Low | View details for Wedbush rating of Sabra Health Care REIT (NASDAQ:SBRA) on 2/29/2024 |
CRM Salesforce | $301.41 -1.4% | 2/29/2024 | Target Raised by | Wedbush | - | Buy -> Buy | $280.00 -> $325.00 | Low | View details for Wedbush rating of Salesforce (NYSE:CRM) on 2/29/2024 |
AI C3.ai | $27.26 +0.7% | 2/29/2024 | Target Lowered by | Wedbush | - | Overweight -> Overweight | $42.00 -> $35.00 | Low | View details for Wedbush rating of C3.ai (NYSE:AI) on 2/29/2024 |
DIN Dine Brands Global | $46.18 +2.8% | 2/29/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $46.00 -> $48.00 | Low | View details for Wedbush rating of Dine Brands Global (NYSE:DIN) on 2/29/2024 |
MRSN Mersana Therapeutics | $4.49 +4.4% | 2/29/2024 | Upgraded by | Wedbush | Analyst D. Nierengarten | Neutral -> Outperform | $2.00 -> $7.00 | Low | View details for Wedbush rating of Mersana Therapeutics (NASDAQ:MRSN) on 2/29/2024 |
YOU Clear Secure | $21.15 -1.3% | 2/28/2024 | Reiterated by | Wedbush | - | Neutral | $23.00 | Low | View details for Wedbush rating of Clear Secure (NYSE:YOU) on 2/28/2024 |
GTHX G1 Therapeutics | $4.47 +4.2% | 2/28/2024 | Reiterated by | Wedbush | - | Outperform | $4.00 -> $5.00 | Low | View details for Wedbush rating of G1 Therapeutics (NASDAQ:GTHX) on 2/28/2024 |
KNSA Kiniksa Pharmaceuticals | $19.99 +0.1% | 2/28/2024 | Reiterated by | Wedbush | - | Outperform | $28.00 | Low | View details for Wedbush rating of Kiniksa Pharmaceuticals (NASDAQ:KNSA) on 2/28/2024 |
MNKD MannKind | $4.63 -5.7% | 2/28/2024 | Reiterated by | Wedbush | - | Outperform | $10.00 | Low | View details for Wedbush rating of MannKind (NASDAQ:MNKD) on 2/28/2024 |
RDFN Redfin | $6.20 +5.1% | 2/28/2024 | Reiterated by | Wedbush | - | Neutral | $8.00 | Low | View details for Wedbush rating of Redfin (NASDAQ:RDFN) on 2/28/2024 |
AAPL Apple | $173.31 +2.1% | 2/28/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $250.00 | Low | View details for Wedbush rating of Apple (NASDAQ:AAPL) on 2/28/2024 |
SNOW Snowflake | $160.05 +1.3% | 2/28/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $144.00 -> $210.00 | Low | View details for Wedbush rating of Snowflake (NYSE:SNOW) on 2/28/2024 |
APLS Apellis Pharmaceuticals | $58.49 -0.9% | 2/28/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $60.00 -> $67.00 | Low | View details for Wedbush rating of Apellis Pharmaceuticals (NASDAQ:APLS) on 2/28/2024 |
DNLI Denali Therapeutics | $20.77 +4.5% | 2/28/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $31.00 | Low | View details for Wedbush rating of Denali Therapeutics (NASDAQ:DNLI) on 2/28/2024 |
ARVN Arvinas | $41.33 +0.8% | 2/28/2024 | Target Raised by | Wedbush | Analyst R. Driscoll | Outperform -> Outperform | $33.00 -> $59.00 | Low | View details for Wedbush rating of Arvinas (NASDAQ:ARVN) on 2/28/2024 |
XNCR Xencor | $22.42 +4.1% | 2/28/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $36.00 -> $34.00 | Low | View details for Wedbush rating of Xencor (NASDAQ:XNCR) on 2/28/2024 |
ZNTL Zentalis Pharmaceuticals | $15.19 +7.8% | 2/28/2024 | Target Raised by | Wedbush | Analyst R. Driscoll | Neutral -> Neutral | $12.00 -> $15.00 | Low | View details for Wedbush rating of Zentalis Pharmaceuticals (NASDAQ:ZNTL) on 2/28/2024 |
RGNX REGENXBIO | $22.18 +2.4% | 2/28/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $21.00 | Low | View details for Wedbush rating of REGENXBIO (NASDAQ:RGNX) on 2/28/2024 |
VRDN Viridian Therapeutics | $17.51 +0.8% | 2/28/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $39.00 -> $40.00 | Low | View details for Wedbush rating of Viridian Therapeutics (NASDAQ:VRDN) on 2/28/2024 |
KURA Kura Oncology | $21.17 +3.7% | 2/28/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $37.00 | Low | View details for Wedbush rating of Kura Oncology (NASDAQ:KURA) on 2/28/2024 |
RVLV Revolve Group | $20.55 +1.7% | 2/28/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $12.00 -> $17.00 | Low | View details for Wedbush rating of Revolve Group (NYSE:RVLV) on 2/28/2024 |
SHOCKING Crypto Leak… (Ad) A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products.
If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE…
The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Claim your free seat by clicking here now. |
LOW Lowe's Companies | $253.33 +0.8% | 2/28/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $215.00 -> $250.00 | Low | View details for Wedbush rating of Lowe’s Companies (NYSE:LOW) on 2/28/2024 |
AZO AutoZone | $3,192.79 +0.0% | 2/28/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $2,950.00 -> $3,400.00 | Low | View details for Wedbush rating of AutoZone (NYSE:AZO) on 2/28/2024 |
NUVL Nuvalent | $76.64 +1.2% | 2/27/2024 | Reiterated by | Wedbush | - | Outperform | $99.00 | Low | View details for Wedbush rating of Nuvalent (NASDAQ:NUVL) on 2/27/2024 |
BEAM Beam Therapeutics | $33.96 +2.2% | 2/27/2024 | Reiterated by | Wedbush | - | Outperform | $48.00 -> $57.00 | Low | View details for Wedbush rating of Beam Therapeutics (NASDAQ:BEAM) on 2/27/2024 |
PLTK Playtika | $6.99 +0.7% | 2/27/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $14.75 -> $11.50 | Low | View details for Wedbush rating of Playtika (NASDAQ:PLTK) on 2/27/2024 |
ZM Zoom Video Communications | $66.62 +0.4% | 2/27/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $80.00 | Low | View details for Wedbush rating of Zoom Video Communications (NASDAQ:ZM) on 2/27/2024 |
U Unity Software | $27.00 +1.1% | 2/27/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $50.00 -> $33.50 | Low | View details for Wedbush rating of Unity Software (NYSE:U) on 2/27/2024 |
CAVA CAVA Group | $69.16 +1.4% | 2/27/2024 | Reiterated by | Wedbush | Analyst N. Setyan | Outperform -> Outperform | $59.00 -> $65.00 | Low | View details for Wedbush rating of CAVA Group (NYSE:CAVA) on 2/27/2024 |
FATE Fate Therapeutics | $7.34 +7.0% | 2/27/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $3.00 -> $7.00 | Low | View details for Wedbush rating of Fate Therapeutics (NASDAQ:FATE) on 2/27/2024 |
RVMD Revolution Medicines | $31.72 +5.7% | 2/27/2024 | Target Raised by | Wedbush | Analyst R. Driscoll | Outperform -> Outperform | $41.00 -> $42.00 | Low | View details for Wedbush rating of Revolution Medicines (NASDAQ:RVMD) on 2/27/2024 |
JANX Janux Therapeutics | $37.92 -2.4% | 2/27/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $24.00 -> $53.00 | Low | View details for Wedbush rating of Janux Therapeutics (NASDAQ:JANX) on 2/27/2024 |
CELH Celsius | $83.43 -8.5% | 2/27/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $75.00 -> $90.00 | Low | View details for Wedbush rating of Celsius (NASDAQ:CELH) on 2/27/2024 |
DPZ Domino's Pizza | $492.13 +1.9% | 2/26/2024 | Reiterated by | Wedbush | - | Outperform | $445.00 -> $520.00 | Low | View details for Wedbush rating of Domino’s Pizza (NYSE:DPZ) on 2/26/2024 |
TCRX TScan Therapeutics | $8.30 +3.9% | 2/26/2024 | Reiterated by | Wedbush | - | Outperform | $9.00 | Low | View details for Wedbush rating of TScan Therapeutics (NASDAQ:TCRX) on 2/26/2024 |
RITM Rithm Capital | $11.33 +2.1% | 2/26/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $13.00 | Low | View details for Wedbush rating of Rithm Capital (NYSE:RITM) on 2/26/2024 |
SWTX SpringWorks Therapeutics | $50.10 +1.8% | 2/26/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $60.00 -> $70.00 | Low | View details for Wedbush rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 2/26/2024 |
KDP Keurig Dr Pepper | $30.59 -0.5% | 2/26/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $37.00 -> $35.00 | Low | View details for Wedbush rating of Keurig Dr Pepper (NASDAQ:KDP) on 2/26/2024 |
NHI National Health Investors | $61.82 +1.9% | 2/26/2024 | Upgraded by | Wedbush | Analyst R. Anderson | Neutral -> Outperform | $57.00 -> $64.00 | Low | View details for Wedbush rating of National Health Investors (NYSE:NHI) on 2/26/2024 |
AMC AMC Entertainment | $4.34 +6.4% | 2/23/2024 | Reiterated by | Wedbush | Analyst A. Reese | Neutral -> Neutral | $6.00 | Low | View details for Wedbush rating of AMC Entertainment (NYSE:AMC) on 2/23/2024 |
SNBR Sleep Number | $15.70 +4.7% | 2/23/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $12.00 -> $13.50 | Low | View details for Wedbush rating of Sleep Number (NASDAQ:SNBR) on 2/23/2024 |
W Wayfair | $67.57 +4.3% | 2/23/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $70.00 | Low | View details for Wedbush rating of Wayfair (NYSE:W) on 2/23/2024 |
FND Floor & Decor | $129.64 +1.4% | 2/23/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $115.00 -> $125.00 | Low | View details for Wedbush rating of Floor & Decor (NYSE:FND) on 2/23/2024 |
AXTI AXT | $4.89 +3.8% | 2/23/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $6.00 | Low | View details for Wedbush rating of AXT (NASDAQ:AXTI) on 2/23/2024 |
PRGS Progress Software | $52.63 0.0% | 2/23/2024 | Target Raised by | Wedbush | Analyst D. Ives | Outperform -> Outperform | $65.00 -> $67.00 | Low | View details for Wedbush rating of Progress Software (NASDAQ:PRGS) on 2/23/2024 |
BKNG Booking | $3,673.50 +0.3% | 2/23/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $3,850.00 | Low | View details for Wedbush rating of Booking (NASDAQ:BKNG) on 2/23/2024 |
MELI MercadoLibre | $1,522.65 -1.0% | 2/23/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $1,800.00 -> $2,000.00 | Low | View details for Wedbush rating of MercadoLibre (NASDAQ:MELI) on 2/23/2024 |
IMAX IMAX | $16.16 +2.9% | 2/23/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $22.00 | Low | View details for Wedbush rating of IMAX (NYSE:IMAX) on 2/23/2024 |
ZD Ziff Davis | $63.10 +0.8% | 2/23/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $75.00 -> $78.00 | Low | View details for Wedbush rating of Ziff Davis (NASDAQ:ZD) on 2/23/2024 |
NICE NICE | $255.59 -2.3% | 2/23/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $230.00 -> $270.00 | Low | View details for Wedbush rating of NICE (NASDAQ:NICE) on 2/23/2024 |
COGT Cogent Biosciences | $6.52 +11.6% | 2/23/2024 | Target Raised by | Wedbush | Analyst D. Nierengarten | Neutral -> Neutral | $5.00 -> $10.00 | Low | View details for Wedbush rating of Cogent Biosciences (NASDAQ:COGT) on 2/23/2024 |
CRI Carter's | $83.14 +1.3% | 2/23/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $67.00 -> $78.00 | Low | View details for Wedbush rating of Carter’s (NYSE:CRI) on 2/23/2024 |
CHUY Chuy's | $33.93 +3.9% | 2/23/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $41.00 -> $38.00 | Low | View details for Wedbush rating of Chuy’s (NASDAQ:CHUY) on 2/23/2024 |
RKT Rocket Companies | $14.55 +5.7% | 2/23/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $13.00 | Low | View details for Wedbush rating of Rocket Companies (NYSE:RKT) on 2/23/2024 |
ARDX Ardelyx | $7.41 -0.1% | 2/23/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $13.00 | Low | View details for Wedbush rating of Ardelyx (NASDAQ:ARDX) on 2/23/2024 |
ALIT Alight | $9.79 -0.1% | 2/22/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $13.00 | Low | View details for Wedbush rating of Alight (NYSE:ALIT) on 2/22/2024 |
EPAM EPAM Systems | $276.37 +3.0% | 2/22/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $320.00 -> $340.00 | Low | View details for Wedbush rating of EPAM Systems (NYSE:EPAM) on 2/22/2024 |
UTHR United Therapeutics | $243.27 -1.9% | 2/22/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $308.00 | Low | View details for Wedbush rating of United Therapeutics (NASDAQ:UTHR) on 2/22/2024 |
RCUS Arcus Biosciences | $18.24 +9.5% | 2/22/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $30.00 | Low | View details for Wedbush rating of Arcus Biosciences (NYSE:RCUS) on 2/22/2024 |
UFPI UFP Industries | $121.79 +3.3% | 2/22/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $102.00 | Low | View details for Wedbush rating of UFP Industries (NASDAQ:UFPI) on 2/22/2024 |
NVDA NVIDIA | $902.50 -2.5% | 2/22/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $800.00 -> $850.00 | Low | View details for Wedbush rating of NVIDIA (NASDAQ:NVDA) on 2/22/2024 |
ETSY Etsy | $67.99 +3.3% | 2/22/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $85.00 -> $80.00 | Low | View details for Wedbush rating of Etsy (NASDAQ:ETSY) on 2/22/2024 |
MTTR Matterport | $1.95 +7.7% | 2/22/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $5.00 -> $4.00 | Low | View details for Wedbush rating of Matterport (NASDAQ:MTTR) on 2/22/2024 |
WING Wingstop | $365.88 -0.6% | 2/22/2024 | Target Raised by | Wedbush | Analyst N. Setyan | Outperform -> Outperform | $330.00 -> $340.00 | Low | View details for Wedbush rating of Wingstop (NASDAQ:WING) on 2/22/2024 |
BROS Dutch Bros | $33.15 +0.2% | 2/22/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $37.00 | Low | View details for Wedbush rating of Dutch Bros (NYSE:BROS) on 2/22/2024 |
JACK Jack in the Box | $70.47 +2.8% | 2/22/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $83.00 -> $79.00 | Low | View details for Wedbush rating of Jack in the Box (NASDAQ:JACK) on 2/22/2024 |
CAKE Cheesecake Factory | $36.37 +5.2% | 2/22/2024 | Reiterated by | Wedbush | Analyst N. Setyan | Outperform -> Outperform | $40.00 | Low | View details for Wedbush rating of Cheesecake Factory (NASDAQ:CAKE) on 2/22/2024 |
SPRY ARS Pharmaceuticals | $9.96 -0.4% | 2/21/2024 | Reiterated by | Wedbush | - | Outperform | $19.00 | Low | View details for Wedbush rating of ARS Pharmaceuticals (NASDAQ:SPRY) on 2/21/2024 |
TOL Toll Brothers | $127.40 +1.2% | 2/21/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $87.00 | Low | View details for Wedbush rating of Toll Brothers (NYSE:TOL) on 2/21/2024 |
HD Home Depot | $385.89 +1.6% | 2/21/2024 | Reiterated by | Wedbush | Analyst S. Basham | Outperform -> Outperform | $380.00 | Low | View details for Wedbush rating of Home Depot (NYSE:HD) on 2/21/2024 |
FUBO fuboTV | $1.56 +3.3% | 2/21/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $5.00 | Low | View details for Wedbush rating of fuboTV (NYSE:FUBO) on 2/21/2024 |
my top trade on these 9 tickers (Ad) This indicator is uniquely designed to spot the most significant moves in the top stocks out there (and according to our backtesting it has historically nailed these moves with a stunning 90% accuracy).
Now, most folks have been saying NVDA is way overbought or overpriced. They didn’t want to “buy at the top” 6 weeks ago… Or again 4 weeks ago… or again 2 weeks ago…
And it’s not their fault! That’s what all the talking heads were saying too.
But the Apex Indicator would have clearly shown that these were opportunities to buy.
And, sure enough, Nvidia slammed through the recommended targets again and again. Click Here for this Powerful Workshop |
PLTK Playtika | $6.99 +0.7% | 2/21/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $14.75 | Low | View details for Wedbush rating of Playtika (NASDAQ:PLTK) on 2/21/2024 |
BYON Beyond | $36.02 +1.4% | 2/21/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $33.00 -> $35.00 | Low | View details for Wedbush rating of Beyond (NYSE:BYON) on 2/21/2024 |
LGIH LGI Homes | $114.20 +1.4% | 2/21/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $97.00 -> $88.00 | Low | View details for Wedbush rating of LGI Homes (NASDAQ:LGIH) on 2/21/2024 |
AZO AutoZone | $3,192.79 +0.0% | 2/20/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $2,950.00 | Low | View details for Wedbush rating of AutoZone (NYSE:AZO) on 2/20/2024 |
CVNA Carvana | $90.31 -0.6% | 2/20/2024 | Target Raised by | Wedbush | Analyst S. Basham | Neutral -> Neutral | $40.00 -> $50.00 | Low | View details for Wedbush rating of Carvana (NYSE:CVNA) on 2/20/2024 |
SRPT Sarepta Therapeutics | $130.23 +1.5% | 2/20/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $224.00 | Low | View details for Wedbush rating of Sarepta Therapeutics (NASDAQ:SRPT) on 2/20/2024 |
SQ Block | $83.18 -0.7% | 2/20/2024 | Reiterated by | Wedbush | Analyst M. Katri | Outperform -> Outperform | $90.00 | Low | View details for Wedbush rating of Block (NYSE:SQ) on 2/20/2024 |
AIP Arteris | $7.50 +0.7% | 2/20/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $17.00 | Low | View details for Wedbush rating of Arteris (NASDAQ:AIP) on 2/20/2024 |
ABR Arbor Realty Trust | $13.39 +4.2% | 2/20/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $17.00 | Low | View details for Wedbush rating of Arbor Realty Trust (NYSE:ABR) on 2/20/2024 |
TPH Tri Pointe Homes | $37.93 +3.1% | 2/20/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral -> Neutral | $32.00 | Low | View details for Wedbush rating of Tri Pointe Homes (NYSE:TPH) on 2/20/2024 |
DOOR Masonite International | $131.20 0.0% | 2/20/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $133.00 | Low | View details for Wedbush rating of Masonite International (NYSE:DOOR) on 2/20/2024 |
HR Healthcare Realty Trust | $13.95 +4.3% | 2/20/2024 | Downgraded by | Wedbush | Analyst R. Anderson | Outperform -> Neutral | $19.00 -> $15.00 | Low | View details for Wedbush rating of Healthcare Realty Trust (NYSE:HR) on 2/20/2024 |
HPP Hudson Pacific Properties | $6.40 +4.6% | 2/20/2024 | Downgraded by | Wedbush | Analyst R. Anderson | Outperform -> Neutral | $11.00 -> $7.50 | Low | View details for Wedbush rating of Hudson Pacific Properties (NYSE:HPP) on 2/20/2024 |
COIN Coinbase Global | $256.70 -3.8% | 2/16/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $180.00 -> $200.00 | Low | View details for Wedbush rating of Coinbase Global (NASDAQ:COIN) on 2/16/2024 |
DASH DoorDash | $138.88 -1.0% | 2/16/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $92.00 -> $115.00 | Low | View details for Wedbush rating of DoorDash (NASDAQ:DASH) on 2/16/2024 |
PANW Palo Alto Networks | $282.26 -1.5% | 2/16/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $350.00 -> $425.00 | Low | View details for Wedbush rating of Palo Alto Networks (NASDAQ:PANW) on 2/16/2024 |
INTC Intel | $43.77 +4.2% | 2/16/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $40.00 | Low | View details for Wedbush rating of Intel (NASDAQ:INTC) on 2/16/2024 |
W Wayfair | $67.57 +4.3% | 2/16/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $70.00 | Low | View details for Wedbush rating of Wayfair (NYSE:W) on 2/16/2024 |
ROKU Roku | $65.58 +1.4% | 2/16/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $120.00 | Low | View details for Wedbush rating of Roku (NASDAQ:ROKU) on 2/16/2024 |
RNG RingCentral | $34.87 +2.3% | 2/16/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $40.00 | Low | View details for Wedbush rating of RingCentral (NYSE:RNG) on 2/16/2024 |
GLOB Globant | $204.74 +2.9% | 2/16/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $250.00 | Low | View details for Wedbush rating of Globant (NYSE:GLOB) on 2/16/2024 |
GPC Genuine Parts | $155.18 +1.7% | 2/16/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $140.00 | Low | View details for Wedbush rating of Genuine Parts (NYSE:GPC) on 2/16/2024 |
RARE Ultragenyx Pharmaceutical | $46.82 +3.0% | 2/16/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $47.00 -> $48.00 | Low | View details for Wedbush rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 2/16/2024 |
TVTX Travere Therapeutics | $7.67 +1.3% | 2/16/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $13.00 | Low | View details for Wedbush rating of Travere Therapeutics (NASDAQ:TVTX) on 2/16/2024 |
WD Walker & Dunlop | $100.87 +6.0% | 2/16/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $130.00 | Low | View details for Wedbush rating of Walker & Dunlop (NYSE:WD) on 2/16/2024 |
NVDA NVIDIA | $902.50 -2.5% | 2/16/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $800.00 -> $850.00 | Low | View details for Wedbush rating of NVIDIA (NASDAQ:NVDA) on 2/16/2024 |
KMX CarMax | $86.98 +1.4% | 2/16/2024 | Reiterated by | Wedbush | Analyst S. Basham | Outperform -> Outperform | $90.00 | Low | View details for Wedbush rating of CarMax (NYSE:KMX) on 2/16/2024 |
FND Floor & Decor | $129.64 +1.4% | 2/16/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $85.00 -> $115.00 | Low | View details for Wedbush rating of Floor & Decor (NYSE:FND) on 2/16/2024 |
BJRI BJ's Restaurants | $35.74 +7.7% | 2/16/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $40.00 | Low | View details for Wedbush rating of BJ’s Restaurants (NASDAQ:BJRI) on 2/16/2024 |
TXRH Texas Roadhouse | $154.27 +1.3% | 2/16/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $145.00 -> $160.00 | Low | View details for Wedbush rating of Texas Roadhouse (NASDAQ:TXRH) on 2/16/2024 |
WEN Wendy's | $18.90 +3.8% | 2/16/2024 | Target Lowered by | Wedbush | Analyst N. Setyan | Neutral -> Neutral | $20.00 -> $19.00 | Low | View details for Wedbush rating of Wendy’s (NASDAQ:WEN) on 2/16/2024 |
NTLA Intellia Therapeutics | $27.02 +2.9% | 2/15/2024 | Reiterated by | Wedbush | - | Neutral | $29.00 | Low | View details for Wedbush rating of Intellia Therapeutics (NASDAQ:NTLA) on 2/15/2024 |
GEO The GEO Group | $14.21 -2.1% | 2/15/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $14.00 | Low | View details for Wedbush rating of The GEO Group (NYSE:GEO) on 2/15/2024 |
MGPI MGP Ingredients | $85.80 +3.4% | 2/15/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $135.00 | Low | View details for Wedbush rating of MGP Ingredients (NASDAQ:MGPI) on 2/15/2024 |
APP AppLovin | $68.86 -3.1% | 2/15/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $58.50 -> $67.00 | Low | View details for Wedbush rating of AppLovin (NASDAQ:APP) on 2/15/2024 |
PEGA Pegasystems | $65.10 -0.8% | 2/15/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $58.00 | Low | View details for Wedbush rating of Pegasystems (NASDAQ:PEGA) on 2/15/2024 |
TRIP Tripadvisor | $27.85 -0.5% | 2/15/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $20.00 | Low | View details for Wedbush rating of Tripadvisor (NASDAQ:TRIP) on 2/15/2024 |
GLUE Monte Rosa Therapeutics | $7.04 +6.8% | 2/15/2024 | Initiated by | Wedbush | - | Outperform | $11.00 | Low | View details for Wedbush rating of Monte Rosa Therapeutics (NASDAQ:GLUE) on 2/15/2024 |
CGEM Cullinan Oncology | $17.73 +5.7% | 2/15/2024 | Initiated by | Wedbush | - | Outperform | $30.00 | Low | View details for Wedbush rating of Cullinan Oncology (NASDAQ:CGEM) on 2/15/2024 |
WING Wingstop | $365.88 -0.6% | 2/14/2024 | Target Raised by | Wedbush | Analyst N. Setyan | Outperform -> Outperform | $280.00 -> $330.00 | Low | View details for Wedbush rating of Wingstop (NASDAQ:WING) on 2/14/2024 |
SHAK Shake Shack | $104.28 +1.9% | 2/14/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $80.00 | Low | View details for Wedbush rating of Shake Shack (NYSE:SHAK) on 2/14/2024 |
BYON Beyond | $36.02 +1.4% | 2/14/2024 | Reiterated by | Wedbush | - | Outperform | $33.00 | Low | View details for Wedbush rating of Beyond (NYSE:BYON) on 2/14/2024 |
LYFT Lyft | $19.48 -0.8% | 2/14/2024 | Reiterated by | Wedbush | - | Neutral | $14.00 -> $15.00 | Low | View details for Wedbush rating of Lyft (NASDAQ:LYFT) on 2/14/2024 |
ABNB Airbnb | $166.41 -0.6% | 2/14/2024 | Reiterated by | Wedbush | - | Neutral | $150.00 -> $160.00 | Low | View details for Wedbush rating of Airbnb (NASDAQ:ABNB) on 2/14/2024 |
DENN Denny's | $9.06 +4.9% | 2/14/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $11.00 -> $10.50 | Low | View details for Wedbush rating of Denny’s (NASDAQ:DENN) on 2/14/2024 |
SHOP Shopify | $78.62 +0.1% | 2/13/2024 | Reiterated by | Wedbush | Analyst S. Devitt | Neutral | $68.00 | Low | View details for Wedbush rating of Shopify (NYSE:SHOP) on 2/13/2024 |
GTHX G1 Therapeutics | $4.47 +4.2% | 2/13/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $5.00 -> $4.00 | Low | View details for Wedbush rating of G1 Therapeutics (NASDAQ:GTHX) on 2/13/2024 |
CNK Cinemark | $18.06 +2.7% | 2/13/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $20.00 | Low | View details for Wedbush rating of Cinemark (NYSE:CNK) on 2/13/2024 |
YMAB Y-mAbs Therapeutics | $16.50 +5.1% | 2/12/2024 | Reiterated by | Wedbush | - | Outperform | $12.00 -> $18.00 | Low | View details for Wedbush rating of Y-mAbs Therapeutics (NASDAQ:YMAB) on 2/12/2024 |
CMRX Chimerix | $1.01 +2.0% | 2/12/2024 | Reiterated by | Wedbush | - | Outperform | $6.00 | Low | View details for Wedbush rating of Chimerix (NASDAQ:CMRX) on 2/12/2024 |
NUVL Nuvalent | $76.64 +1.2% | 2/12/2024 | Reiterated by | Wedbush | - | Outperform | $82.00 -> $99.00 | Low | View details for Wedbush rating of Nuvalent (NASDAQ:NUVL) on 2/12/2024 |
BIIB Biogen | $216.34 +2.0% | 2/12/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $239.00 -> $245.00 | Low | View details for Wedbush rating of Biogen (NASDAQ:BIIB) on 2/12/2024 |
COOP Mr. Cooper Group | $78.01 +3.0% | 2/12/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $80.00 -> $85.00 | Low | View details for Wedbush rating of Mr. Cooper Group (NASDAQ:COOP) on 2/12/2024 |
RGNX REGENXBIO | $22.18 +2.4% | 2/12/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $21.00 | Low | View details for Wedbush rating of REGENXBIO (NASDAQ:RGNX) on 2/12/2024 |
BLDR Builders FirstSource | $209.87 +1.4% | 2/12/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $175.00 -> $225.00 | Low | View details for Wedbush rating of Builders FirstSource (NYSE:BLDR) on 2/12/2024 |
DBD Diebold Nixdorf | $34.46 -0.4% | 2/12/2024 | Reiterated by | Wedbush | Analyst M. Bryson | Neutral -> Neutral | $25.00 | Low | View details for Wedbush rating of Diebold Nixdorf (NYSE:DBD) on 2/12/2024 |
AAPL Apple | $173.31 +2.1% | 2/12/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $250.00 | Low | View details for Wedbush rating of Apple (NASDAQ:AAPL) on 2/12/2024 |
CXW CoreCivic | $15.66 +0.1% | 2/9/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $17.00 -> $18.00 | Low | View details for Wedbush rating of CoreCivic (NYSE:CXW) on 2/9/2024 |
AFRM Affirm | $36.72 -1.6% | 2/9/2024 | Reiterated by | Wedbush | - | Underperform -> Underperform | $20.00 | Low | View details for Wedbush rating of Affirm (NASDAQ:AFRM) on 2/9/2024 |
ROKU Roku | $65.58 +1.4% | 2/9/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $120.00 | Low | View details for Wedbush rating of Roku (NASDAQ:ROKU) on 2/9/2024 |